Chinese insurers lead $150m rounds in biotech startup METiS

Chinese insurers lead $150m rounds in biotech startup METiS

Innovative Drugs

06 April, 2022

AI China Life Private Equity Investment METiS Therapeutics PICC Capital XtalPi

Printed by Unregistered user on Fri, 04 Jul 2025 19:07:41 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round

Venture Capital

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU

Read more from Greater China

China’s EV rivalry spills over to Thailand, tests local production goals

People Digest: responsAbility appoints CEO; Gaw Capital names data centre platform head